Lyell Immunopharma, Inc. (LYEL)

24.00 -0.81 (-3.26%) USD  |  NASDAQ  |  Jan 30, 16:00
24.06 +0.06 (+0.23%) After-Hours: 20:00
More

Lyell Immunopharma EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Ratios (EV) Definition

View Enterprise Value Ratios (EV) Definition
Start Trial

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

View EV to Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

View EV to Assets (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade

EV to Assets (Quarterly) Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Earnings Upgrade